Concord Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has informed the stock exchanges that the trading window for its shares will be closed from 1st October 2025 until 48 hours after the company declares its unaudited financial results for the quarter ended 30th September 2025. This is a standard compliance measure under SEBI's insider trading regulations, meaning all designated employees and their immediate relatives cannot buy or sell the company's shares during this period. The board meeting date to approve the Q2 FY26 results has not yet been announced but will be communicated separately. This filing is routine and purely procedural in nature.
No direct impact on shareholders or stock price is expected from this announcement. It is a regulatory formality that simply signals upcoming quarterly earnings results are around the corner, which investors should watch for.